Kaskela Law LLC is investigating Pactiv Evergreen Inc. (NASDAQ: PTVE) (“Pactiv”) on behalf of the company’s current shareholders.

On December 9, 2024, Pactiv announced that it had agreed to be acquired by Novolex at a price of $18.00 per share in cash.  Following the closing of the proposed transaction, Pactiv’s current stockholders will be cashed out of their investment position and the company’s shares will no longer be publicly traded.

The investigation seeks to determine whether Pactiv’s officers and/or directors violated the securities laws in agreeing to sell the company at $18.00 per share, and whether $18.00 per share represents sufficient monetary consideration for Pactiv’s investors.

Pactiv shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by completing the form on this page, to receive additional information about this investigation and their legal rights and options.

CONTACT:

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
([email protected])
Adrienne Bell, Esq.
([email protected])
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750